ForesightTM ICE

Collaboration. Navigation. Innovation.

Early results from clinical study

Southlake Regional Health Centre is the leading Canadian research site for the first phase of the Foresight ICE trial.

Read More

“The Foresight ICE has provided us a new option for guiding trans-septal puncture and I see potential in the 3D imaging that we will be able to take advantage of in several EP and structural cases.”

Dr. Atul Verma
Director Arrhythmia Services
Southlake Regional Health Centre

Product News

Foresight™ ICE System Receives Clearance for New Features

Conavi is pleased to announce 510(k) clearance from the FDA for our Foresight ICE System expanded feature set. The enhancements include Color Doppler, Pulsed-Wave Doppler, 2D and 3D measurements, and ECG-gated 3D image acquisition.

Learn more

CONAVI MEDICAL ANNOUNCES HEALTH CANADA APPROVAL

We are pleased to announce the approval from Health Canada to market the Foresight™ ICE System in Canada.

Learn more

Foresight ICE System™

Our Foresight ICE System™ gives users new features: Forward looking and 3D intracardiac ultrasound capabilities.

Play Button Icon Play Medical Animation

Company News

icon_conavi
Conavi Medical Welcomes Peter Wehrly to the Board of Directors

We are pleased to announce that Mr. Pete Wehrly has been appointed to our Board of Directors.

Pete is the former group president of developed markets at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). He held profit and loss responsibility for the marketing and sale of products to all developed markets outside the U.S. between 2013 and 2015. He departed following the $42-billion sale of Covidien to Medtronic Inc. in 2015.

Learn more

nsha_colour_logo2
Conavi Partners with Nova Scotia Health Authority and Government of Canada to Advance Patient Care

Conavi is pleased to announce that we are spearheading a collaborative effort to develop an imaging and tissue cutting probe for guided cardiovascular surgeries. The miniaturized probe leverages ultrasound technology for both imaging and precision cutting, allowing physicians to diagnose and treat serious conditions in a minimally invasive manner.

The Government of Canada is investing $2.6+ million over five years in the Nova Scotia Health Authority (NSHA) to develop the endoscope prototype. Throughout the development, Conavi will lend our medical and technological expertise to assist the NSHA in taking the solution from concept to creation. Upon creation, Conavi will commercialize the solution for cardiovascular surgical applications, allowing patients worldwide to benefit from improved clinical outcomes.

Fellow Toronto-based company Synaptive Medical will also assist in developing the solution and will likewise commercialize the solution for neurological applications.

Read more here.

daic3
DAIC Recognizes Conavi’s Innovation

Conavi is pleased to announce that our Foresight ICE System has been identified by Diagnostic and Interventional Cardiology (DAIC) as among the most innovative new technologies at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, DC.

Reaching more than 25,000 healthcare professionals, DAIC is an award-winning cardiac technology publication. This year’s TCT allowed DAIC to become acquainted with Conavi’s Foresight ICE System—the first catheter-based system capable of providing both 2D and 3D ultrasound images of the cardiac anatomy around the circumference of the catheter’s tip.

Recognizing the clinical significance of our solution, DAIC singles out the Foresight ICE System in a video posted to its website. See the video here (we appear at the 3:18 mark).

It's clear that there's a need. We have a path to get there.

Dr. Brian Courtney